Tamiflu against avian flu made in China

Introduction: yesterday afternoon, Shanghai Pharmaceutical Group Co., Ltd announced that Shanghai Pharmaceutical Group has been officially authorized by Roche to produce and sell oseltamivir (trade name "Tamiflu"), and the oseltamivir produced by it will supply government orders to prevent and control influenza pandemic It is reported that Shanghai Pharmaceutical Group strives to form a production capacity of 200000 people per month in about six months According to the agreement, the name "Tamiflu" will not be used for the products produced by Shangyao, but its composition and quality will be the same as that of "Tamiflu" produced by Roche, and the price of domestic drugs will be lower than that of "Tamiflu" According to a statement released by Swiss pharmaceutical giant Roche on the 12th, Xinhua news agency said the company decided to choose 12 partners to produce Tamiflu, including major pharmaceutical enterprises from all over the world However, Roche did not disclose the names of 11 other cooperative enterprises except Shanghai Pharmaceutical Group "In addition to publicly inviting third parties to produce Tamiflu, we have also established partnerships with 12 pharmaceutical companies By 2007, our annual output can meet the needs of 300 million patients." Said William Burns, general manager of Roche's pharmaceutical division According to the current orders from all countries, the production capacity of Tamiflu can meet the demand, Burns said "Although we haven't found a company that can determine the delivery time in the first half of 2006, our existing partners can meet the market demand and expand the coverage." Said burns Tamiflu is believed to be the most effective drug known against the H5N1 avian influenza virus As an antibacterial drug, Tamiflu can alleviate the symptoms of patients with avian influenza, but it can not cure the disease American biotechnology company "Gilead" owns the patent of Tamiflu, while Roche owns the exclusive commercial production right of Tamiflu Since 2003, about 70 people around the world have died of avian influenza Due to the fear that the avian influenza virus will be transmitted to people after mutation and spread in large scale among people, the demand for Tamiflu in various countries around the world has increased significantly They have asked Roche to transfer the production license to increase production ■ key words: Tamiflu, Xinhua news agency, Tamiflu, also known as oseltamivir, is an oral antiviral drug for the treatment of influenza, not a vaccine This kind of drugs can prevent the spread of influenza virus in the body In this way, Tamiflu can effectively fight against all clinically relevant influenza virus strains and can be used for influenza prevention and treatment It is recommended by the World Health Organization to prevent and treat highly pathogenic avian influenza It has been proved that Tamiflu can effectively treat influenza in adults and children over 1 year old, and effectively prevent influenza in adults and adolescents over 13 years old In 1996, Roche obtained the right to develop and sell the drug globally from Gilead Between 1999 and 2000, Tamiflu was listed in North America (the United States and Canada) and Switzerland By 2002-2003, Tamiflu was listed in all major European markets More than 33 million patients in about 80 countries have used Tamiflu In December 2001, Tamiflu was listed in China Tamiflu's patent protection period is up to 2016.